Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
40.12
-1.82 (-4.34%)
Nov 17, 2026, 3:00 PM CST
SHA:688513 Market Cap
SHA:688513 has a market cap or net worth of 6.95 billion as of November 16, 2026. It is the 9,538th most valuable company in the world and the 2,074th biggest in China. Its market cap has decreased by 29.63% in one year.
Market Cap
6.95B
Enterprise Value
5.47B
Revenue
1.30B
Global Rank
Country Rank
#2,074 China
PE Ratio
25.40
ChartMarket Cap Chart
Since September 2, 2020, SHA:688513's market cap has decreased from 8.97B to 6.95B, a decrease of -22.59%. That is a compound annual growth rate of -4.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 6.95B | -35.28% |
| Dec 31, 2025 | 10.73B | 104.34% |
| Dec 31, 2024 | 5.25B | -31.43% |
| Dec 29, 2023 | 7.66B | 4.83% |
| Dec 30, 2022 | 7.31B | 31.12% |
| Dec 31, 2021 | 5.57B | -2.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vcanbio Cell & Gene Engineering Corp., | 7.65B |
| InventisBio | 7.64B |
| Jiangxi Fushine Pharmaceutical | 7.33B |
| BeBetter Med | 7.30B |
| Daan Gene | 7.28B |
| Novogene | 7.24B |
| Aurisco Pharmaceutical | 7.17B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 6.96B |